A Phase 1, Randomized, Double-blind, Double-dummy, Placebo-controlled, 5-period, Crossover Study Assessing the Effects of Rapastinel Compared to Alprazolam, Ketamine, and Placebo on Simulated Driving Performance in Normal Healthy Participants
Latest Information Update: 15 Jul 2019
At a glance
- Drugs Rapastinel (Primary) ; Alprazolam; Ketamine
- Indications Major depressive disorder; Substance-related disorders
- Focus Adverse reactions
- Sponsors Allergan
Most Recent Events
- 09 Jul 2019 Status changed from active, no longer recruiting to completed.
- 22 Mar 2019 Planned End Date changed from 22 Apr 2019 to 4 Apr 2019.
- 22 Mar 2019 Planned primary completion date changed from 15 Mar 2019 to 29 Mar 2019.